NRT Smoking Cessation Aids in Norway
NRT SMOKING CESSATION AIDS IN NORWAY
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
the Inconvenience of Smoking and Healthy Lifestyles Promote Sales
Snus and E-cigarettes Remain A Threat To Forecast Growth
Growing Interest in New Products and Formulations
Competitive Landscape
Johnson & Johnson Consumer Nordic Leads
Niconovum Increases Its Value Share
New Brands Have Difficulty Penetrating the Market
Category Indicators
Table 1 Number of Smokers by Gender 2013-2018
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2013-2018
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2013-2018
Table 4 Sales of NRT Gum by Flavour: % Value 2013-2018
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2014-2018
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2015-2018
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023
Executive Summary
Modest Growth Due To Maturity
Demographic Trends and the Weather Affect Sales of Consumer Health Products
Norwegians Are Reluctant To Try New Brands in OTC Categories
Store-based Retailing Remains the Main Channel; Albeit Internet Retailing Is Growing
Most Trends Are Projected To Continue Throughout the Forecast Period
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 10 Life Expectancy at Birth 2013-2018
Market Data
Table 11 Sales of Consumer Health by Category: Value 2013-2018
Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format: % Value 2013-2018
Table 17 Distribution of Consumer Health by Format and Category: % Value 2018
Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Sources
Summary 2 Research Sources
NRT smoking cessation aids is expected to see continued healthy growth over the forecast period, as Norwegians, especially women, are projected to quit smoking at a similar rate as seen in the review period. The smoking ban in public indoor areas, including cafés, restaurants and bars, as well as offices, has led to growing inconvenience for smokers, as they need to go outside to smoke. The number of smokers has therefore declined on an annual basis, and in 2018 stood at about 8% of the total po...
Euromonitor International's NRT Smoking Cessation Aids in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.